Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia
Clinical trial NCT06566885 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06566885
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-10
- Primary completion
- 2026-09-30
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.